arrow
I

Inge Christoffer Olsen

University of Oslo
H指数:40
被引数:6,253

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial

抗肿瘤坏死因子撤药或长期治疗在溃疡性结肠炎中的应用(BIOSTOP):一项多中心开放标签随机对照试验

2026-08-060
PRE
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion

替奈普酶在急性中央视网膜动脉阻塞中的随机试验

2026-01-293
PRE
Comparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial

挪威院前急性疼痛治疗中吸入性甲氧氟烷、鼻内芬太尼和静脉吗啡的比较(PreMeFen):一项随机、非劣效性、三臂、III期临床试验

2025-11-200
PRE
Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI)

急性病毒性呼吸道感染住院患者药物治疗核心结局指标集(COSAVRI)方案

2025-09-090
OAAI
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials

Janus kinase抑制剂在因COVID-19住院的成人中的效果:一项随机临床试验的系统评价和个体参与者数据荟萃分析

2025-05-130
OA
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
2024-07-055
OAAI
EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION ON FREQUENCY OF FECAL INCONTINENCE SYMPTOMS IN SYSTEMIC SCLEROSIS PATIENTS WITH MODERATETO SEVERE LOWER GASTROINTESTINAL DISEASE

粪菌移植对伴有中重度下消化道疾病的系统性硬化症患者粪便失禁症状频率的疗效

2024-06-010
PRE
3-YEAR RESULTS OF TAPERING TNFi TO WITHDRAWAL COMPARED TO STABLE TNFi AMONG RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION: A MULTICENTER RANDOMIZED TRIAL

3年随访结果:在持续缓解的类风湿关节炎患者中,将TNFi剂量递减至停药与维持稳定TNFi剂量进行比较:一项多中心随机试验

2024-06-010
PRE
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
2024-05-011
PRE
Effects of remdesivir in patients hospitalised with COVID-19 a systematic review and individual patient data meta- analysis of randomised controlled trials

remdesivir对新型冠状病毒肺炎住院患者的影响随机对照试验的系统评价和个体患者数据荟萃分析

2023-05-0165
OAAI
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia

在泛欧洲学术临床试验中实施集中式药物警戒系统: 来自EU-Response和conect4children联盟的经验

2023-02-085
OA
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

baricitinib治疗严重或危重新型冠状病毒肺炎成人住院患者的疗效和安全性 (bari-solidact): 一项随机、双盲、安慰剂对照的3期试验

2023-01-1021
OAAI
Immunocompromised patients have been neglected in COVID-19 trials: a call for action

免疫功能低下的患者在新型冠状病毒肺炎试验中被忽视: 呼吁采取行动

2022-09-0121
OA
Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations
2022-03-1749
OA